Shopping Cart 0
Cart Subtotal
USD 0

International Stem Cell Corp (ISCO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

International Stem Cell Corp (ISCC) is a clinical stage biotechnology company that develops stem cell technology solutions. The company develops parthenogenesis, a stem cell technology that improves the field of regenerative medicine. It provides stem cells such as embryonic stem cells, adult stem cells, induced pluripotent stem cells, and parthenogenetic stem cells. ISCC uses human parthenogenetic stem cells (hpSC) to treat severe diseases of the central nervous system, joints and liver. The company has also developed a new class of pluripotent human stem cells derived from unfertilized eggs. It also conducts clinical trials for the treatment of moderate to severe Parkinson's disease. ISCC is headquartered in Carlsbad, California, the US.

International Stem Cell Corp (ISCO)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

International Stem Cell Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

International Stem Cell Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

International Stem Cell Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

International Stem Cell Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

International Stem Cell Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

International Stem Cell Corp, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

International Stem Cell Enters into Research Agreement with Florey Institute of Neuroscience and Mental Health 11

International Stem Cell Enters into Research Agreement with Rohto Pharma 12

Equity Offering 13

International Stem Cell Raises USD0.5 Million in Private Placement of Shares 13

International Stem Cell to Raise USD2.5 Million in Private Placement of Preferred Stock 14

International Stem Cell Files Registration Statement for Private Placement of Shares and Warrants 16

International Stem Cell to Raise USD2.5 Million in Private Placement of Preferred Shares and Warrants 17

International Stem Cell Completes Private Placement Of Shares For USD 0.3 Million 19

International Stem Cell Completes Public Offering Of Units For USD 3 Million 20

International Stem Cell Completes Private Placement Of Shares For USD 1 Million 21

International Stem Cell Completes Private Placement Of Series G Convertible Preference Stock For USD 5 Million 22

International Stem Cell Corp-Key Competitors 23

International Stem Cell Corp-Key Employees 24

International Stem Cell Corp-Locations And Subsidiaries 25

Head Office 25

Other Locations & Subsidiaries 25

Joint Venture 25

Recent Developments 26

Strategy And Business Planning 26

Jul 10, 2018: International Stem Cell Expands Manufacturing Capabilities for Biomedical Products 26

Sep 26, 2017: International Stem Cell to Expand its Revenue Generating Biomedical Businesses to Support Ongoing and Future Clinical Trials 27

Financial Announcements 28

Aug 15, 2018: International Stem Cell announces record sales and operating results for the three and six-months ended June 30, 2018 28

May 22, 2018: International Stem Cell Announces Operating Results for the Quarter Ended March 31, 2018 29

Apr 10, 2018: International Stem Cell Announces 2017 Fourth Quarter and Year-End Results 30

Nov 17, 2017: International Stem Cell Announces Operating Results for the Three and Nine-Months ended September 30, 2017 31

Aug 14, 2017: International Stem Cell Announces Operating Results for the Three and Six-Months ended June 30, 2017 32

May 17, 2017: International Stem Cell Announces Operating Results for the Quarter ended March 31, 2017 33

Apr 05, 2017: International Stem Cell Announces 2016 Fourth Quarter and Year-End Results 34

Product News 35

Oct 09, 2017: International Stem Cell Developed 3D Bioprinting Technology Targeted to Treat Liver Diseases 35

May 30, 2018: International Stem Cell Published Technology for Cartilage Generation in Journal of Tissue Engineering and Regenerative Medicine Technology 36

Other Significant Developments 37

Aug 06, 2018: International Stem Cell developed 3D liver structures 37

Appendix 38

Methodology 38

About GlobalData 38

Contact Us 38

Disclaimer 38


List Of Figure

List of Figures

International Stem Cell Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

International Stem Cell Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

International Stem Cell Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

International Stem Cell Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

International Stem Cell Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

International Stem Cell Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

International Stem Cell Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

International Stem Cell Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9


List Of Table

List of Tables

International Stem Cell Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2

International Stem Cell Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

International Stem Cell Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

International Stem Cell Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

International Stem Cell Corp, Deals By Therapy Area, 2012 to YTD 2018 9

International Stem Cell Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

International Stem Cell Enters into Research Agreement with Florey Institute of Neuroscience and Mental Health 11

International Stem Cell Enters into Research Agreement with Rohto Pharma 12

International Stem Cell Raises USD0.5 Million in Private Placement of Shares 13

International Stem Cell to Raise USD2.5 Million in Private Placement of Preferred Stock 14

International Stem Cell Files Registration Statement for Private Placement of Shares and Warrants 16

International Stem Cell to Raise USD2.5 Million in Private Placement of Preferred Shares and Warrants 17

International Stem Cell Completes Private Placement Of Shares For USD 0.3 Million 19

International Stem Cell Completes Public Offering Of Units For USD 3 Million 20

International Stem Cell Completes Private Placement Of Shares For USD 1 Million 21

International Stem Cell Completes Private Placement Of Series G Convertible Preference Stock For USD 5 Million 22

International Stem Cell Corp, Key Competitors 23

International Stem Cell Corp, Key Employees 24

International Stem Cell Corp, Other Locations 25

International Stem Cell Corp, Subsidiaries 25

International Stem Cell Corp, Joint Venture 25

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

International Stem Cell Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.